Efficacy and safety of combined androgen blockade with antiandrogen for advanced prostate cancer

BACKGROUND: Combined androgen blockade (cab) is a promising treatment modality for prostate cancer (pca). In the present meta-analysis, we compared the efficacy and safety of first-line cab using an antiandrogen (aa) with castration monotherapy in patients with advanced pca. METHODS: PubMed, embase,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Curr Oncol
Autores principales: Yang, Y., Chen, R., Sun, T., Zhao, L., Liu, F., Ren, S., Wang, H., Lu, X., Gao, X., Xu, C., Sun, Y.
Formato: Artigo
Lenguaje:Inglês
Publicado: Multimed Inc. 2019
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380654/
https://ncbi.nlm.nih.gov/pubmed/30853808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4203
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares